Trizepatide 40mg-Synedica

£ 250

Mounjaro 40mg R&D Use Only

Function: Dual-agonist peptide formula designed to support scientific studies on metabolic signaling, appetite regulation, and energy-balance pathways.

Focus: Used in controlled research investigating GLP-1 and GIP receptor interactions and their combined influence on weight-management mechanisms.

Status: Research-grade investigational compound intended exclusively for laboratory and educational use. Not approved for human consumption, medical treatment, or therapeutic applications.

Category: Brand:

Description

The Synedica Tirzepatide 40mg Injection Pen Kit is considered one of the most advanced modern solutions for medical weight management. Tirzepatide—also known by its popular reference name “Mounjaro”—is a dual-agonist medication that helps reduce appetite and promote meaningful weight loss. It works by activating the GLP-1 and GIP receptors, two natural hormonal pathways responsible for controlling fullness and appetite, allowing users to feel satisfied with smaller amounts of food.

The Synedica Tirzepatide 40mg Pen Kit includes:

  • 1 Ă— injection pen
  • 12 Ă— disposable needles
  • 1 Ă— instruction booklet

Each pen contains 40mg of tirzepatide, which can be administered as four full 10mg doses or in adjustable increments of 2.5mg, 5mg, 7.5mg, or 10mg.

Recommended Dosage

  • Weeks 1–4: 2.5mg weekly
  • Weeks 5–8: 5mg weekly
  • After Week 8: May be increased to 7.5mg or 10mg if needed and tolerated
  • As with all medications, users should always consult a doctor, pharmacist, or healthcare professional before beginning treatment.

The Synedica Tirzepatide 40mg Injection Pen Kit is available at selected pharmacies within Germany and may be provided free of charge to eligible individuals covered under Gesetzliche Krankenversicherung (GKV).